Author

Fei Yu

h-index 2 View on Semantic Scholar

We have 3 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Berberine and metabolic dysfunction-associated steatotic liver disease: a global analysis of molecular mechanisms, translational challenges and research frontiers

Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide. Berberine (BBR), a bioactive monomer derived from traditional Chinese medicine, demonstrates remarkable multi-target pharmacological properties in regulating glucose and lipid metaboli...

Fei Yu, Si-Han Yin, Jia-Yu Zhu et al. · Frontiers in Nutrition · 0 citations

Review Open access Sep 2026

Research Trends and Hotspots in Mendelian Randomization Studies of Liver Diseases: A Bibliometric and Visualization Analysis

Abstract This study conducted a bibliometric analysis of Mendelian randomization (MR) research in liver diseases from 2014 to 2025 using the Web of Science Core Collection (WoSCC) and PubMed databases. A total of 304 WoSCC records and 10 clinical studies were included. Publications showed a steady upward trend, with Ch...

Jia-Yu Zhu, Sheng-Ping Luo, Fei Yu et al. · Hepatic Medicine : Evidence... · 0 citations

Open access Aug 2026

Tea and liver fibrosis: a bibliometric analysis of mechanisms, translational challenges, and emerging trends

With advances in nanomedicine and pharmaceutical technologies, coupled with rigorously designed multicenter randomized controlled trials, tea-derived bioactives are anticipated to overcome current limitations and establish clinical value in liver fibrosis prevention and adjuvant therapy.

Fei Yu, Si-Han Yin, Jia-Yu Zhu et al. · Frontiers in Nutrition · 0 citations